{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:06:14Z","timestamp":1790539574532,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-01548"],"award-info":[{"award-number":["2017-01548"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["SFO Epidemiology"],"award-info":[{"award-number":["SFO Epidemiology"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Findings from molecular studies suggesting that several infectious agents cause sarcoidosis are intriguing yet conflicting and likely biased due to their cross-sectional design. As done in other inflammatory diseases to overcome this issue, prospectively-collected register data could be used, but reverse causation is a threat when the onset of disease is difficult to establish. We investigated the association between infectious diseases and sarcoidosis to understand if they are etiologically related. We conducted a nested case\u2013control study (2009\u20132013) using incident sarcoidosis cases from the Swedish National Patient Register (n\u2009=\u20094075) and matched general population controls (n\u2009=\u200940,688). Infectious disease was defined using inpatient\/outpatient visits and\/or antimicrobial dispensations starting 3\u00a0years before diagnosis\/matching. Adjusted odds ratios (aOR) of sarcoidosis were estimated using conditional logistic regression and tested for robustness assuming the presence of reverse causation bias. The aOR of sarcoidosis associated with history of infectious disease was 1.19 (95% confidence interval [CI] 1.09, 1.29; 21% vs. 16% exposed cases and controls, respectively). Upper respiratory and ocular infections conferred the highest OR. Findings were similar when we altered the infection definition or varied the infection-sarcoidosis latency period (1\u20137\u00a0years). In bias analyses assuming one in 10 infections occurred because of preclinical sarcoidosis, the observed association was completely attenuated (aOR 1.02; 95% CI 0.90, 1.15). Our findings, likely induced by reverse causation due to preclinical sarcoidosis, do not support the hypothesis that common symptomatic infectious diseases are etiologically linked to sarcoidosis. Caution for reverse causation bias is required when the real disease onset is unknown.<\/jats:p>","DOI":"10.1007\/s10654-020-00611-w","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T20:15:47Z","timestamp":1581452147000},"page":"1087-1097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case\u2013control study"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9769-324X","authenticated-orcid":false,"given":"Marios","family":"Rossides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0433-0616","authenticated-orcid":false,"given":"Johan","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-7057","authenticated-orcid":false,"given":"Anders","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0473-3984","authenticated-orcid":false,"given":"Johan","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3817-8288","authenticated-orcid":false,"given":"Daniela","family":"Di Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3677-9736","authenticated-orcid":false,"given":"Elizabeth V.","family":"Arkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"611_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","volume":"6","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6:389\u2013402.","journal-title":"Lancet Respir Med"},{"key":"611_CR2","doi-asserted-by":"crossref","unstructured":"Statement on sarcoidosis. Am J Respir Crit Care Med 1999;160:736\u201355.","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"611_CR3","doi-asserted-by":"publisher","first-page":"1800385","DOI":"10.1183\/13993003.00385-2018","volume":"52","author":"M Rossides","year":"2018","unstructured":"Rossides M, Grunewald J, Eklund A, Kullberg S, Di Giuseppe D, Askling J, et al. Familial aggregation and heritability of sarcoidosis: a Swedish nested case\u2013control study. Eur Respir J. 2018;52:1800385.","journal-title":"Eur Respir J"},{"key":"611_CR4","doi-asserted-by":"publisher","first-page":"e0154716","DOI":"10.1371\/journal.pone.0154716","volume":"11","author":"C Fang","year":"2016","unstructured":"Fang C, Huang H, Xu Z. Immunological evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. PLoS ONE. 2016;11:e0154716.","journal-title":"PLoS ONE"},{"key":"611_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1165\/rcmb.2015-0212OC","volume":"55","author":"JE Rotsinger","year":"2016","unstructured":"Rotsinger JE, Celada LJ, Polosukhin VV, Atkinson JB, Drake WP. Molecular analysis of sarcoidosis granulomas reveals antimicrobial targets. Am J Respir Cell Mol Biol. 2016;55:128\u201334.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"611_CR6","first-page":"262","volume":"30","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Hu Y, Li H. Role of Propionibacterium acnes in sarcoidosis: a meta-analysis. Sarcoidosis Vasc Diffus Lung Dis. 2013;30:262\u20137.","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"611_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/bjophthalmol-2016-309248","volume":"101","author":"H Goto","year":"2017","unstructured":"Goto H, Usui Y, Umazume A, Uchida K, Eishi Y. Propionibacterium acnes as a possible pathogen of granuloma in patients with ocular sarcoidosis. Br J Ophthalmol. 2017;101:1510\u20133.","journal-title":"Br J Ophthalmol"},{"key":"611_CR8","doi-asserted-by":"publisher","first-page":"e0179980","DOI":"10.1371\/journal.pone.0179980","volume":"12","author":"N Asakawa","year":"2017","unstructured":"Asakawa N, Uchida K, Sakakibara M, Omote K, Noguchi K, Tokuda Y, et al. Immunohistochemical identification of Propionibacterium acnes in granuloma and inflammatory cells of myocardial tissues obtained from cardiac sarcoidosis patients. PLoS ONE. 2017;12:e0179980.","journal-title":"PLoS ONE"},{"key":"611_CR9","doi-asserted-by":"publisher","first-page":"e0192408","DOI":"10.1371\/journal.pone.0192408","volume":"13","author":"Y Suzuki","year":"2018","unstructured":"Suzuki Y, Uchida K, Takemura T, Sekine M, Tamura T, Furukawa A, et al. Propionibacterium acnes-derived insoluble immune complexes in sinus macrophages of lymph nodes affected by sarcoidosis. PLoS ONE. 2018;13:e0192408.","journal-title":"PLoS ONE"},{"key":"611_CR10","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/1756-185X.13009","volume":"21","author":"M Saghafi","year":"2018","unstructured":"Saghafi M, Rezaieyazdi Z, Nabavi S, Mirfeizi Z, Sahebari M, Salari M. HTLV-1 seroprevalance in sarcoidosis. A clinical and laboratory study in northeast of Iran. Int J Rheum Dis. 2018;21:1309\u201313.","journal-title":"Int J Rheum Dis"},{"key":"611_CR11","first-page":"1","volume":"2014","author":"M Ter\u010delj","year":"2014","unstructured":"Ter\u010delj M, Stopin\u0161ek S, Ihan A, Salobir B, Sim\u010di\u010d S, Rylander R. Fungal exposure and low levels of IL-10 in patients with sarcoidosis. Pulm Med. 2014;2014:1\u20134.","journal-title":"Pulm Med"},{"key":"611_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/sji.12273","volume":"81","author":"M Suchankova","year":"2015","unstructured":"Suchankova M, Paulovicova E, Paulovicova L, Majer I, Tedlova E, Novosadova H, et al. Increased antifungal antibodies in bronchoalveolar lavage fluid and serum in pulmonary sarcoidosis. Scand J Immunol. 2015;81:259\u201364.","journal-title":"Scand J Immunol"},{"key":"611_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12931-019-1013-2","volume":"20","author":"A Becker","year":"2019","unstructured":"Becker A, Vella G, Galata V, Rentz K, Beisswenger C, Herr C, et al. The composition of the pulmonary microbiota in sarcoidosis\u2014an observational study. Respir Res. 2019;20:46.","journal-title":"Respir Res"},{"key":"611_CR14","doi-asserted-by":"publisher","first-page":"1600746","DOI":"10.1183\/13993003.00746-2016","volume":"50","author":"A Zimmermann","year":"2017","unstructured":"Zimmermann A, Knecht H, H\u00e4sler R, Zissel G, Gaede KI, Hofmann S, et al. Atopobium and Fusobacterium as novel candidates for sarcoidosis-associated microbiota. Eur Respir J. 2017;50:1600746.","journal-title":"Eur Respir J"},{"key":"611_CR15","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","volume":"170","author":"LS Newman","year":"2004","unstructured":"Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"611_CR16","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","volume":"48","author":"EV Arkema","year":"2016","unstructured":"Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J. 2016;48:1690\u20139.","journal-title":"Eur Respir J"},{"key":"611_CR17","doi-asserted-by":"publisher","first-page":"e0176859","DOI":"10.1371\/journal.pone.0176859","volume":"12","author":"D Begh\u00e8","year":"2017","unstructured":"Begh\u00e8 D, Dall\u2019Asta L, Garavelli C, Pastorelli AA, Muscarella M, Saccani G, et al. Sarcoidosis in an Italian province. Prevalence and environmental risk factors. PLoS ONE. 2017;12:e0176859.","journal-title":"PLoS ONE"},{"key":"611_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1136\/thoraxjnl-2016-209032","volume":"71","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Crowson CS, Matteson EL. Seasonal variation in incidence of sarcoidosis: a population-based study, 1976\u20132013. Thorax. 2016;71:1164\u20136.","journal-title":"Thorax"},{"key":"611_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jamadermatol.2013.4646","volume":"149","author":"WP Drake","year":"2013","unstructured":"Drake WP, Oswald-Richter K, Richmond BW, Isom J, Burke VE, Algood H, et al. Oral antimycobacterial therapy in chronic cutaneous sarcoidosis. JAMA Dermatol. 2013;149:1040\u20139.","journal-title":"JAMA Dermatol"},{"key":"611_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/resp.13482","volume":"24","author":"S Wang","year":"2019","unstructured":"Wang S, Chung C, Huang T, Tsai W, Peng C, Huang K, et al. Bidirectional association between tuberculosis and sarcoidosis. Respirology. 2019;24:467\u201374.","journal-title":"Respirology"},{"key":"611_CR21","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1136\/annrheumdis-2017-211174","volume":"76","author":"J Svensson","year":"2017","unstructured":"Svensson J, Holmqvist M, Lundberg IE, Arkema EV. Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case\u2013control study. Ann Rheum Dis. 2017;76:1803\u20138.","journal-title":"Ann Rheum Dis"},{"key":"611_CR22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/joim.12888","volume":"285","author":"J Mofors","year":"2019","unstructured":"Mofors J, Arkema EV, Bj\u00f6rk A, Westermark L, Kvarnstr\u00f6m M, Forsblad-d\u2019Elia H, et al. Infections increase the risk of developing Sj\u00f6gren\u2019s syndrome. J Intern Med. 2019;285:670\u201380.","journal-title":"J Intern Med"},{"issue":"1311\u20131322","key":"611_CR23","first-page":"e7","volume":"17","author":"JE Axelrad","year":"2019","unstructured":"Axelrad JE, Ol\u00e9n O, Askling J, Lebwohl B, Khalili H, Sachs MC, et al. Gastrointestinal infection increases odds of inflammatory bowel disease in a nationwide case\u2013control study. Clin Gastroenterol Hepatol. 2019;17(1311\u20131322):e7.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"611_CR24","unstructured":"Socialstyrelsen. Kvalitet och inneh\u00e5ll i patientregistret. Utskrivningar fr\u00e5n slutenv\u00e5rden 1964\u20132007 och bes\u00f6k i specialiserad \u00f6ppenv\u00e5rd (exklusive prim\u00e4rv\u00e5rdsbes\u00f6k) 1997\u20132007 [Quality and contents of the National Patient Register]. Stockholm; 2009."},{"key":"611_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","volume":"5","author":"J Grunewald","year":"2019","unstructured":"Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, M\u00fcller-Quernheim J. Sarcoidosis. Nat Rev Dis Prim. 2019;5:45.","journal-title":"Nat Rev Dis Prim"},{"key":"611_CR26","doi-asserted-by":"publisher","first-page":"105846","DOI":"10.1016\/j.rmed.2019.105846","volume":"161","author":"M Rossides","year":"2020","unstructured":"Rossides M, Kullberg S, Eklund A, Grunewald J, Arkema EV. Sarcoidosis diagnosis and treatment in Sweden: a register-based assessment of variations by region and calendar period. Respir Med. 2020;161:105846.","journal-title":"Respir Med"},{"key":"611_CR27","doi-asserted-by":"publisher","first-page":"1701815","DOI":"10.1183\/13993003.01815-2017","volume":"51","author":"M Rossides","year":"2018","unstructured":"Rossides M, Kullberg S, Askling J, Eklund A, Grunewald J, Arkema EV. Sarcoidosis mortality in Sweden: a population-based cohort study. Eur Respir J. 2018;51:1701815.","journal-title":"Eur Respir J"},{"key":"611_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/s-0037-1602380","volume":"38","author":"B Karakaya","year":"2017","unstructured":"Karakaya B, Kaiser Y, van Moorsel C, Grunewald J. L\u00f6fgren\u2019s syndrome: diagnosis, management, and disease pathogenesis. Semin Respir Crit Care Med. 2017;38:463\u201376.","journal-title":"Semin Respir Crit Care Med"},{"key":"611_CR29","first-page":"256","volume":"31","author":"AK Gerke","year":"2014","unstructured":"Gerke AK, Tang F, Pendergast J, Cavanaugh JE, Polgreen PM. The high frequency of healthcare use in patients one year prior to a sarcoidosis diagnosis. Sarcoidosis Vasc Diffus Lung Dis. 2014;31:256\u201361.","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"611_CR30","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.rmed.2018.09.016","volume":"144","author":"EV Arkema","year":"2018","unstructured":"Arkema EV, Eklund A, Grunewald J, Bruze G. Work ability before and after sarcoidosis diagnosis in Sweden. Respir Med. 2018;144:S7\u201312.","journal-title":"Respir Med"},{"key":"611_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.rmed.2019.04.004","volume":"152","author":"M Gade Sikj\u00e6r","year":"2019","unstructured":"Gade Sikj\u00e6r M, Hilberg O, Ibsen R, Bock K, L\u00f8kke A. Direct and indirect economic and health consequences related to sarcoidosis in Denmark: a national register-based study. Respir Med. 2019;152:7\u201313.","journal-title":"Respir Med"},{"key":"611_CR32","unstructured":"Statistiska Centralbyr\u00e5n. Konsumentprisindex [Consumer price index] [Internet]. 2018. https:\/\/www.scb.se\/hitta-statistik\/statistik-efter-amne\/priser-och-konsumtion\/konsumentprisindex\/konsumentprisindex-kpi\/. Accessed 20 Aug 2018."},{"key":"611_CR33","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/art.24328","volume":"60","author":"K Hemminki","year":"2009","unstructured":"Hemminki K, Li X, Sundquist J, Sundquist K. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum. 2009;60:661\u20138.","journal-title":"Arthritis Rheum"},{"key":"611_CR34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","volume":"20","author":"S Schneeweiss","year":"2009","unstructured":"Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20:512\u201322.","journal-title":"Epidemiology"},{"key":"611_CR35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1183\/09031936.00002607","volume":"30","author":"D Gupta","year":"2007","unstructured":"Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J. 2007;30:508\u201316.","journal-title":"Eur Respir J"},{"key":"611_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12890-016-0332-z","volume":"16","author":"T Esteves","year":"2016","unstructured":"Esteves T, Aparicio G, Garcia-Patos V. Is there any association between sarcoidosis and infectious agents? A systematic review and meta-analysis. BMC Pulm Med. 2016;16:165.","journal-title":"BMC Pulm Med"},{"key":"611_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajo.2018.09.013","volume":"198","author":"SP Ma","year":"2019","unstructured":"Ma SP, Rogers SL, Hall AJ, Hodgson L, Brennan J, Stawell RJ, et al. Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis. Am J Ophthalmol. 2019;198:30\u20136.","journal-title":"Am J Ophthalmol"},{"key":"611_CR38","first-page":"393","volume":"16","author":"J Mooney","year":"2019","unstructured":"Mooney J, Chang E, Lalla D, Papoyan E, Raimundo K, Reddy SR, et al. Potential delays in diagnosis of idiopathic pulmonary fibrosis in medicare beneficiaries. Ann Am Thorac Soc. 2019;16:393\u20136.","journal-title":"Ann Am Thorac Soc"},{"key":"611_CR39","doi-asserted-by":"publisher","first-page":"R159","DOI":"10.1186\/ar4342","volume":"15","author":"EV Arkema","year":"2013","unstructured":"Arkema EV, Goldstein BL, Robinson W, Sokolove J, Wagner CA, Malspeis S, et al. Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case\u2013control study. Arthritis Res Ther. 2013;15:R159.","journal-title":"Arthritis Res Ther"},{"key":"611_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdv.15043","volume":"32","author":"B Dr\u00e9no","year":"2018","unstructured":"Dr\u00e9no B, P\u00e9castaings S, Corvec S, Veraldi S, Khammari A, Roques C. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. J Eur Acad Dermatol Venereol. 2018;32:5\u201314.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"611_CR41","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1164\/rccm.201507-1372OC","volume":"193","author":"NV Rivera","year":"2016","unstructured":"Rivera NV, Ronninger M, Shchetynsky K, Franke A, N\u00f6then MM, M\u00fcller-Quernheim J, et al. High-density genetic mapping identifies new susceptibility variants in sarcoidosis phenotypes and shows genomic-driven phenotypic differences. Am J Respir Crit Care Med. 2016;193:1008\u201322.","journal-title":"Am J Respir Crit Care Med"},{"key":"611_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","volume":"179","author":"J Grunewald","year":"2009","unstructured":"Grunewald J, Eklund A. L\u00f6fgren\u2019s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med. 2009;179:307\u201312.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-020-00611-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10654-020-00611-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-020-00611-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T07:01:22Z","timestamp":1612940482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10654-020-00611-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1007\/s10654-020-00611-w","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"assertion":[{"value":"28 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"EVA reports Grants from the Swedish Research Council (Vetenskapsr\u00e5det; Project No. 2017-01548), the Swedish Heart\u2013Lung Foundation (Hj\u00e4rt-Lungfonden; Project No. 20170412), Karolinska Institutet\u2019s Strategic Research Area in Epidemiology (SfoEpi), and the Swedish Society of Medicine (Svenska L\u00e4kares\u00e4llskapet) during the conduct of the study. MR, SK, JA, AE, JG, and DDG report no conflicts of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}